申请人:Boehringer Mannheim GmbH
公开号:US06121322A1
公开(公告)日:2000-09-19
The invention provides novel azulene derivatives of general formula I ##STR1## wherein R.sub.1 to R.sub.6 have the significance given in the description, as well as their tautomers, enantiomers, diastereomers, racemates and physiologically compatible salts or esters and substances which are hydrolyzed or metabolized in vivo to compounds of formula I. The invention is also concerned with a process and intermediates for the manufacture of the above compounds, pharmaceutical compositions which contain such compounds as well as the use of these compounds in the treatment of inflammatory conditions.
该发明提供了一种通式I的新型蓝紫烯衍生物##STR1##其中R.sub.1至R.sub.6在描述中给出的含义,以及它们的互变异构体、对映异构体、非对映异构体、消旋体和生理兼容性盐或酯,以及在体内水解或代谢为通式I化合物的物质。该发明还涉及制备上述化合物的过程和中间体,含有这些化合物的药物组合物,以及在治疗炎症性疾病中使用这些化合物。